These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36680603)

  • 21. Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
    Shigematsu Y; Inamura K; Yamamoto N; Mise Y; Saiura A; Ishikawa Y; Takahashi S; Kanda H
    BMC Cancer; 2018 Oct; 18(1):980. PubMed ID: 30326864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of endoscopic or surgical resection in T1 colorectal cancer patients: a retrospective cohort study.
    Song S; Dou L; Zhang Y; Liu X; Liu Y; He S; Wang G
    Surg Endosc; 2024 Mar; 38(3):1499-1511. PubMed ID: 38242989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients.
    Zhou ZG; Wu XJ; Li LR; Peng ZH; Ding PR; Wang RJ; Pan ZZ
    Chin Med J (Engl); 2011 Jul; 124(14):2132-5. PubMed ID: 21933615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.
    Lee MM; MacKinlay A; Semira C; Schieber C; Jimeno Yepes AJ; Lee B; Wong R; Hettiarachchige CKH; Gunn N; Tie J; Wong HL; Skinner I; Jones IT; Keck J; Kosmider S; Tran B; Field K; Gibbs P
    Clin Colorectal Cancer; 2018 Sep; 17(3):e569-e577. PubMed ID: 29980491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The predictive value of advanced lung cancer inflammation index for short-term outcomes and prognosis of colorectal cancer patients who underwent radical surgery.
    Zhang B; Li ZW; Tong Y; Yuan C; Liu XY; Wei ZQ; Zhang W; Peng D
    Int J Clin Oncol; 2023 Dec; 28(12):1616-1624. PubMed ID: 37700210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
    Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
    J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Eastern Cooperative Oncology Group Performance Status as a prognostic factor of stage I-III colorectal cancer surgery for elderly patients: a multi-institutional retrospective analysis.
    Hanaoka M; Hino H; Shiomi A; Kagawa H; Manabe S; Yamaoka Y; Kato S; Yamauchi S; Kinugasa Y; Sugihara K
    Surg Today; 2022 Jul; 52(7):1081-1089. PubMed ID: 35039939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the initial recurrence site on prognosis after radical surgery for colorectal cancer: a retrospective cohort study.
    Pu H; Chen Y; Shen R; Zhang Y; Yang D; Liu L; Dong X; Yang G
    World J Surg Oncol; 2023 Apr; 21(1):137. PubMed ID: 37101165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer.
    Mima K; Kurashige J; Miyanari N; Morito A; Yumoto S; Matsumoto T; Kosumi K; Inoue M; Mizumoto T; Kubota T; Baba H
    In Vivo; 2020; 34(1):339-346. PubMed ID: 31882497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
    Li Z; Zhu H; Pang X; Mao Y; Yi X; Li C; Lei M; Cheng X; Liang L; Wu J; Ding Y; Yang J; Sun Y; Zhang T; You D; Liu Z
    BMC Cancer; 2022 Sep; 22(1):962. PubMed ID: 36076189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.
    Sugawara K; Kawaguchi Y; Nomura Y; Koike D; Nagai M; Tanaka N
    World J Surg; 2017 Jan; 41(1):295-305. PubMed ID: 27464912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify┬áLess-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
    Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
    Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Horizontal spread of pericolic lymph node metastasis as a prognostic factor for recurrence in Stage III colorectal cancer.
    Sasaki T; Shigeta K; Okabayashi K; Tsuruta M; Seishima R; Matsui S; Kitagawa Y
    Colorectal Dis; 2021 Jun; 23(6):1370-1378. PubMed ID: 33590648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
    Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study.
    Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Ozawa T; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Yamauchi S; Sugihara K; Ishihara S
    BMC Cancer; 2022 May; 22(1):486. PubMed ID: 35501727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
    Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ
    Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.